NASDAQ:VRAX

Virax Biolabs Group Stock Forecast

etoro logo Buy VRAX
*Your capital is at risk
$2.94
-0.320 (-9.82%)
At Close: Jun 30, 2026
AI Analysis AI Analysis of VRAX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add VRAX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Volatile ride for Virax Biolabs Group Limited stock price on Tuesday moving between $2.94 and $3.54
(Updated on Jun 30, 2026)

Sell candidate since Jun 10, 2026 Loss -33.56%

The Virax Biolabs Group Limited stock price fell by -9.82% on the last day (Tuesday, 30th Jun 2026) from $3.26 to $2.94. During the last trading day the stock fluctuated 20.41% from a day low at $2.94 to a day high of $3.54. The price has fallen in 6 of the last 10 days and is down by -31.98% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -329 thousand shares and in total, 74 thousand shares were bought and sold for approximately $217.97 thousand.

The stock has broken the very wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $3.24. A reaction back to this level may hold a second chance to get out before further falls.

VRAX Signals & Forecast

There are few to no technical positive signals at the moment. The Virax Biolabs Group Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.42 and $4.74. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 20, 2026, and so far it has fallen -63.13%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Virax Biolabs Group Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.60. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.600 between high and low, or 20.41%. For the last week the stock has had daily average volatility of 27.99%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VRAX) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Virax Biolabs Group Limited to open at $3.14, and during the day (based on 14 day Average True Range), to move between $2.53 and $3.35, which gives a possible trading interval of +/-$0.83 (+/-32.68%) up or down from last closing price. If Virax Biolabs Group Limited takes out the full calculated possible swing range there will be an estimated 32.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.11 (5.78%) than the support at $2.60 (11.48%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Virax Biolabs Group Limited stock A Buy?

The Virax Biolabs Group Limited stock holds several negative signals and despite the positive trend, we believe Virax Biolabs Group Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.344 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 1, 2026 - $3.14 ( 6.80%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

VRAX Performance

Trading levels for VRAX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.74 27.21%
R2 3.51 19.41%
R1 3.37 14.60%
Price 2.94
S1 2.91 -0.99%
S2 2.77 -5.81%
S3 2.54 -13.61%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.37 14.71%
R2 3.26 10.88%
R1 3.11 5.78%
Price 2.94
S1 2.60 -11.48%
S2 0 -
S3 0 -

FAQ

What is the symbol for Virax Biolabs Group Limited Stock and on which exchange is it traded?
The symbol for Virax Biolabs Group Limited is VRAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Virax Biolabs Group Limited Stock?
The Virax Biolabs Group Limited stock holds several negative signals and despite the positive trend, we believe Virax Biolabs Group Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Virax Biolabs Group Limited Stock?
Virax Biolabs Group Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Virax Biolabs Group Limited Stock.

What's the current price of Virax Biolabs Group Limited Stock?
As of the end of day on the Jun 30, 2026, the price of an Virax Biolabs Group Limited (VRAX) share was $2.94.

What is the 52-week high and low for Virax Biolabs Group Limited Stock?
The 52-week high for Virax Biolabs Group Limited Stock is $28.50 and the 52-week low is $2.50.

What is the market capitalization of Virax Biolabs Group Limited Stock?
As of the Jun 30, 2026, the market capitalization of Virax Biolabs Group Limited is 548.678K.

When is the next earnings date for Virax Biolabs Group Limited?
The upcoming earnings date for Virax Biolabs Group Limited is Dec 02, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IIIV
$20.09
5.03% Jun 25
X
XMAX
$8.34
7.31% Jun 24
NMRK
$15.02
1.60% Jun 24
JLL
$299.78
4.44% Jun 24
CAG
$13.43
4.06% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE